Bassersdorf, Switzerland

Oliver Ast

USPTO Granted Patents = 18 

 

 

Average Co-Inventor Count = 9.8

ph-index = 9

Forward Citations = 369(Granted Patents)


Company Filing History:


Years Active: 2016-2024

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):

Title: The Innovations of Oliver Ast: A Trailblazer in Biotherapeutics

Introduction

Oliver Ast is an accomplished inventor hailing from Bassersdorf, Switzerland. With an impressive portfolio of 18 patents to his name, he has made significant contributions to the field of biotherapeutics, particularly in the development of innovative antibody solutions. His work has far-reaching implications for treating various diseases, making him a notable figure in the life sciences industry.

Latest Patents

Among his latest patents, Oliver Ast has developed bispecific antibodies targeting CD3EPSILON and ROR1. This invention is pivotal as it relates to the manufacture and application of these antibodies, which hold promise for therapeutic use. Another significant patent involves immunoconjugates that are antigen-specific. These novel immunoconjugates include a first antigen-binding moiety, an Fc domain, and a single effector moiety, providing a targeted approach to influencing cellular activity. Furthermore, Ast's invention also includes polynucleotides encoding such immunoconjugates, alongside methods for their production and application in disease treatment.

Career Highlights

Oliver has garnered substantial experience working at leading companies in the industry, including Roche Glycart AG and Hoffmann-La Roche Inc. His tenure at these organizations has allowed him to hone his skills and expertise in biotherapeutics, leading to the patent innovations for which he is now recognized.

Collaborations

Throughout his career, Oliver Ast has collaborated with esteemed professionals such as Christian Klein and Pablo Umana. These partnerships have contributed to the development of groundbreaking technologies and innovations in the field of immunology and therapeutic applications.

Conclusion

In summary, Oliver Ast is a significant figure in the field of biotherapeutics, known for his innovative patents and collaborative efforts. His work in developing bispecific antibodies and antigen-specific immunoconjugates reflects his commitment to advancing medical treatments. As research and development continue to evolve, Oliver's contributions will undoubtedly have a lasting impact on the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…